ABNORMAL RESPONSE OF C-MYC EXPRESSION IN BONE-MARROW CELLS FROM MYELODYSPLASTIC SYNDROME PATIENTS TO PHORBOL ESTER

Citation
T. Shiosaka et al., ABNORMAL RESPONSE OF C-MYC EXPRESSION IN BONE-MARROW CELLS FROM MYELODYSPLASTIC SYNDROME PATIENTS TO PHORBOL ESTER, Journal of experimental & clinical cancer research, 13(2), 1994, pp. 125-129
Citations number
NO
Categorie Soggetti
Oncology
ISSN journal
03929078
Volume
13
Issue
2
Year of publication
1994
Pages
125 - 129
Database
ISI
SICI code
0392-9078(1994)13:2<125:AROCEI>2.0.ZU;2-U
Abstract
The abnormal growth and differentiation of bone marrow cells from pati ents with myelodysplastic syndrome (MDS) might be due to impairment of signal transduction pathways leading to an abnormal response to phorb ol ester, eg 12-0-tetradecanoylphorbol 13-acetate (TPA), receptors. Th e impaired signal transduction pathways led to an abnormal response to TPA, determined as the difference in the expression of c-mys before a nd after treatment with TPA. One hour exposure to TPA did not induce c -myc gene expression in normal bone marrow cells. In contrast, the lev els of c-myc gene expression were increased by more than two-fold in M DS bone marrow samples after treatment with TPA. The excess expression of c-myc in MDS samples after exposure to TPA was inhibited by additi on of protein kinase inhibitors (H-7, sphingosine).